Literature DB >> 10381889

Neuregulin signaling in the heart. Dynamic targeting of erbB4 to caveolar microdomains in cardiac myocytes.

Y Y Zhao1, O Feron, C Dessy, X Han, M A Marchionni, R A Kelly.   

Abstract

Two of the neuregulins (NRG1 and NRG2) and their receptors (erbB2 and erbB4) are essential for normal cardiac development and can mediate hypertrophic growth and enhance survival of embryonic, postnatal, and adult rat ventricular myocytes. The expression of erbB4, the predominant NRG receptor in postnatal rat ventricular muscle, declines after midembryogenesis, and its expression is limited to cardiac myocytes. A full-length erbB4 rat cDNA isolated from neonatal ventricular muscle was found to be highly homologous to human erbB4 and contained a caveolin binding motif within the cytoplasmic kinase domain. Using the complementary techniques of detergent-free density-gradient ultracentrifugation of myocyte lysates and coimmunoprecipitation of erbB4 and caveolin-3, the caveolin isoform expressed in cardiac myocytes, erbB4 could be localized (using both approaches) to caveolar microdomains. Moreover, addition of a soluble NRG1, recombinant human glial growth factor 2, resulted in rapid (2-minute) translocation of erbB4 out of caveolar microdomain in cardiac myocytes. Thus, erbB4 is dynamically targeted to caveolar microdomains within cardiac myocytes. Its rapid translocation after NRG1 binding may contribute to receptor desensitization in the continuous presence of ligand.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10381889     DOI: 10.1161/01.res.84.12.1380

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  18 in total

Review 1.  ErbB-4: a receptor tyrosine kinase.

Authors:  W Zhou; G Carpenter
Journal:  Inflamm Res       Date:  2002-02       Impact factor: 4.575

2.  G protein betagamma dimer expression in cardiomyocytes: developmental acquisition of Gbeta3.

Authors:  Vitalyi O Rybin; Susan F Steinberg
Journal:  Biochem Biophys Res Commun       Date:  2008-01-31       Impact factor: 3.575

3.  ErbB-4 and TNF-alpha converting enzyme localization to membrane microdomains.

Authors:  Kristina W Thiel; Graham Carpenter
Journal:  Biochem Biophys Res Commun       Date:  2006-09-28       Impact factor: 3.575

4.  Ligand-dependent recruitment of the ErbB4 signaling complex into neuronal lipid rafts.

Authors:  Li Ma; Yang Z Huang; Graham M Pitcher; Juli G Valtschanoff; Ying H Ma; Lin Y Feng; Bai Lu; Wen C Xiong; Michael W Salter; Richard J Weinberg; Lin Mei
Journal:  J Neurosci       Date:  2003-04-15       Impact factor: 6.167

5.  Defects in caveolin-1 cause dilated cardiomyopathy and pulmonary hypertension in knockout mice.

Authors:  You-Yang Zhao; Yang Liu; Radu-Virgil Stan; Lian Fan; Yusu Gu; Nancy Dalton; Po-Hsien Chu; Kirk Peterson; John Ross; Kenneth R Chien
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-12       Impact factor: 11.205

6.  The role of epidermal growth factor receptor in diabetes-induced cardiac dysfunction.

Authors:  Saghir Akhtar; Ibrahim Fadil Benter
Journal:  Bioimpacts       Date:  2013-01-26

7.  Chronic pharmacologic inhibition of EGFR leads to cardiac dysfunction in C57BL/6J mice.

Authors:  Cordelia J Barrick; Ming Yu; Hann-Hsiang Chao; David W Threadgill
Journal:  Toxicol Appl Pharmacol       Date:  2008-03-07       Impact factor: 4.219

Review 8.  Molecular mechanisms in endothelial regulation of cardiac function.

Authors:  Leena Kuruvilla; Chandrasekharan Cheranellore Kartha
Journal:  Mol Cell Biochem       Date:  2003-11       Impact factor: 3.396

Review 9.  Genetics of Cardiac Developmental Disorders: Cardiomyocyte Proliferation and Growth and Relevance to Heart Failure.

Authors:  Lisa Wilsbacher; Elizabeth M McNally
Journal:  Annu Rev Pathol       Date:  2016-02-24       Impact factor: 23.472

10.  The neuregulin receptor ErbB-4 interacts with PDZ-containing proteins at neuronal synapses.

Authors:  R A Garcia; K Vasudevan; A Buonanno
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-28       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.